Medtronic Invests In Gene Therapy Delivery For Parkinson’s Disease
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is extending its investment in gene therapy delivery to include neurological indications for Parkinson's disease and temporal lobe epilepsy under an agreement with Neurologix